Drugs / Zinc supplementation
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT03717987 | Jan → Sep 2019 | gingival disorder | Cairo University | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04065529 Background | Sep 2019 → Jun 2020 | diarrheal disease | Ferrer Internacional S.A. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zinc supplementation | “zinc supplementation will be given to patients in the intervention arm 4 days prior to Botulinum toxin type A injection” NCT03717987 ↗ |